Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,035.00    -3.50 (-0.34%)
Bid:
1,036.50
Ask:
1,037.00
Spread: 0.50 (0.048%)
Market Cap: £5.06b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Trading update

15 Jan 2021 07:00

RNS Number : 7819L
Babcock International Group PLC
15 January 2021
 

15 January 2021 

Babcock International Group PLC (Babcock or the Group)

Trading update

 

Babcock, the aerospace and defence company, issues the following trading update for the first nine months of the financial year ending 31 March 2021.

 

Group trading

Trading in the third quarter saw a continuation of trends in the first half of the year, with weakness in our civil aviation businesses and a negative impact from COVID-19.

 

Underlying revenue in the nine months year to date (YTD) was £3,399 million (9M 2020: £3,574 million), down 3% on last year excluding disposals and FX. Underlying operating profit in the nine months YTD was £202 million (9M 2020: £320 million), down 34% excluding disposals and FX, with a negative impact from civil nuclear insourcing, COVID-19 and civil aviation.

 

Order intake YTD was £3.1 billion with the Group's order book standing at £16.8 billion at 31 December 2020 (31 March 2020: £17.6 billion).

 

Balance sheet

The Group's net debt1 (excluding lease obligations) at 31 December 2020 was £1,207 million, a reduction of £255 million compared to 31 December 20192. Although this position is higher than that reported at 30 September 2020 of £871 million, it is consistent with the average net debt for the first nine months of this financial year of £1,222 million3.

 

Review of contract profitability and balance sheet

We have recently started a detailed review of our balance sheet and contract profitability. Early indications suggest that there may be negative impacts on the balance sheet and/or income statement for current and/or future years. This review is being supported by an independent accounting firm and the outputs will be reviewed by our auditor (PWC), Audit Committee and Board prior to the publication of our audited results for the year ending 31 March 2021 expected in May.

 

Outlook

Uncertainty remains around the outturn for this financial year, especially given that our fourth quarter is historically our strongest and that the COVID-19 situation has worsened in most of our markets. Given this uncertainty, and the start of our review of contract profitability and balance sheet, we continue not to provide financial guidance for this financial year.

 

Review of strategic priorities

We announced a review of the Group's strategic priorities in November 2020 and this is now well underway. Our focus throughout this review will be on cash delivery, being a strategic partner to the UK Government, international growth, driving innovation across the Group, and transforming our ESG and people agenda. We will outline our refreshed strategy alongside our full year results.

 

David Lockwood, CEO said:

"While trading in the third quarter has continued to reflect the challenges of the first half and there remain a number of near term uncertainties, the fundamental strengths of the Group and the opportunities ahead give us confidence for future years and I look forward to reporting back at the full year results".

 

 

For further information please contact:

 

Babcock International Group PLC

Simon McGough Kate Hill

Director of Investor Relations Group Director of Communications

Tel: +44 (0)7850 978 741 Tel: +44 (0)20 7355 5312

 

FTI Consulting

John Waples / Nick Hasell / Alex Le May

Tel: +44 (0)20 3727 1340

 

 

Notes

1. Net debt includes the benefit of ongoing receivables factoring and supply chain finance programmes.

2. This includes net proceeds from the sales of Context, Holdfast and Conbras of £194 million.

3. Based on the average of nine month end positions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFSEELEFSEFF
Date   Source Headline
8th Jan 20213:23 pmRNSHolding(s) in Company
15th Dec 20207:00 amRNSBabcock appoints new Marine CEO
2nd Dec 20204:24 pmRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSHalf-year results
10th Nov 20207:00 amRNSDirector appointment
28th Oct 20207:00 amRNSAppointment of Chief Corporate Affairs Officer
15th Oct 20209:38 amRNSHolding(s) in Company
13th Oct 20209:00 amRNSChief Innovation & Technology Officer Appointment
9th Oct 20209:00 amRNSType 31 briefing
6th Oct 202011:21 amRNSHolding(s) in Company
30th Sep 202012:47 pmRNSDirector/PDMR Shareholding
30th Sep 20207:00 amRNSBabcock appoints new Chief Financial Officer
21st Sep 20202:56 pmRNSDirector/PDMR Shareholding
15th Sep 202010:20 amRNSDirector/PDMR Shareholding
9th Sep 20208:00 amRNSPublication of Base Prospectus
25th Aug 20209:25 amRNSHolding(s) in Company
18th Aug 20209:44 amRNSHolding(s) in Company
17th Aug 20209:11 amRNSDirector/PDMR Shareholding
14th Aug 20203:40 pmRNSDirector/PDMR Shareholding
14th Aug 20203:39 pmRNSDirector/PDMR Shareholding
4th Aug 20201:39 pmRNSDirector/PDMR Shareholding
4th Aug 202011:33 amRNSResult of AGM
4th Aug 202011:01 amRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSTrading update
31st Jul 20207:00 amRNSDirectorate Change
16th Jul 20209:07 amRNSDirector/PDMR Shareholding
16th Jul 20209:05 amRNSDirector/PDMR Shareholding
16th Jul 20209:05 amRNSDirector/PDMR Shareholding
7th Jul 202011:04 amRNSHolding(s) in Company
7th Jul 202011:02 amRNSHolding(s) in Company
1st Jul 20204:50 pmRNSNotice of AGM
1st Jul 202010:26 amRNSDirector/PDMR Shareholding
1st Jul 20207:00 amRNSBabcock appoints new Chief Executive
11th Jun 20203:52 pmRNSDirector/PDMR Shareholding
11th Jun 20207:00 amRNSFinal Results
19th May 20207:00 amRNSItalian Anti-Trust Authority decision
11th May 20207:00 amRNSRevised date for full year results and AGM
20th Apr 20207:00 amRNSDirector appointment
6th Apr 20207:00 amRNSUpdate on Coronavirus (COVID-19)
19th Mar 20202:47 pmRNSDirector/PDMR Shareholding
6th Mar 20209:43 amRNSSale of Context
14th Feb 202011:23 amRNSHolding(s) in Company
12th Feb 202010:33 amRNSDirector/PDMR Shareholding
12th Feb 20207:00 amRNSTrading Update
5th Feb 20207:00 amRNSDirectorate Changes
20th Jan 20201:52 pmRNSDirector/PDMR Shareholding
16th Jan 20209:13 amRNSDirector Declaration
25th Nov 201912:41 pmRNSContract for Australian Future Submarine programme
20th Nov 201910:55 amRNSDirector/PDMR Shareholding
20th Nov 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.